Ascensus Specialties (Wind Point) Acquires Callery, LLC
September 6, 2019
Ascensus Specialties LLC, a Wind Point Partners–backed chemical producer, has signed a definitive agreement to acquire Callery, LLC, the global leader in boranes and specialty alcoholates. The add-on acquisition will combine complementary reagent chemistry capabilities to create a broader global reagents platform serving pharmaceutical, life sciences and specialty industrial end markets; terms were not disclosed.
- Buyers
- Ascensus Specialties LLC, Wind Point Partners
- Targets
- Callery, LLC
- Sellers
- Edgewater Capital Partners
- Platforms
- Ascensus Specialties LLC
- Industry
- Manufacturing
- Location
- Pennsylvania, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Ascensus Specialties Acquires Strem Chemicals
April 7, 2021
Manufacturing
Ascensus Specialties LLC, a Wind Point Partners-backed specialty chemicals platform, has completed the acquisition of Strem Chemicals, a Newburyport, Massachusetts-based maker of high-purity research-grade catalysts, ligands, organometallics and CVD/ALD precursors. The deal brings Strem's custom synthesis and cGMP manufacturing capabilities into the Ascensus platform to expand lab-to-commercial scale offerings and accelerate R&D and product development.
-
New Mountain Capital and Wind Point Partners Recapitalize Ascensus Specialties
July 7, 2021
Manufacturing
New Mountain Capital has led a recapitalization of Ascensus Specialties, with Wind Point Partners exiting its prior fund position while reinvesting alongside New Mountain through a special purpose vehicle anchored by Blackstone Strategic Partners. Ascensus, a Bellevue, Washington-based specialty chemicals manufacturer and global leader in borohydride, borane and specialty alcoholate reagents, will use the new capital to support R&D, product innovation and continued growth across pharmaceutical, microelectronics and other specialty end markets.
-
Ascensus Specialties Acquires Wychem Limited from AURELIUS Equity Opportunities
December 13, 2021
Manufacturing
Ascensus Specialties LLC has acquired Wychem Limited, a UK-based independent fine chemical manufacturer, from AURELIUS Equity Opportunities. The acquisition expands Ascensus' European manufacturing footprint and adds Wychem's capabilities in aromatic compounds, halogenation and multi-step intermediates for pharmaceutical APIs; financial terms were not disclosed by Ascensus, while AURELIUS reported a 10.6x money-over-money multiple on the sale.
-
Tilley-Phoenix Group Acquires Callahan Chemical Company
January 5, 2022
Industrial Services
Tilley-Phoenix Group, a portfolio company of SK Capital Partners, has acquired Callahan Chemical Company, a regional distributor of specialty ingredients. The acquisition expands Tilley-Phoenix's product portfolio, value-added services (formulation, QA/QC, blending and repackaging) and geographic reach in regulated end markets including food & beverage, personal care and pharmaceuticals.
-
Ascensus Specialties Acquires Strem Chemicals UK (Strem UK)
November 9, 2022
Pharmaceuticals
Ascensus Specialties LLC acquired the business and certain assets of Strem Chemicals UK (Strem UK), the independent UK distributor of Ascensus high‑purity research reagents and CVD/ALD precursors. The deal brings Strem UK’s customer relationships into Ascensus’ global distribution footprint, with Strem UK senior leadership remaining to support a smooth transition.
-
ALTIVIA Acquires Axiall's Specialty Phosgene Derivatives Business
February 26, 2015
Manufacturing
ALTIVIA has signed a definitive agreement to acquire the Specialty Phosgene Derivatives business and related assets from Axiall Corporation, including the La Porte, Texas chemical production facility. The transaction transfers roughly 120 facility employees to ALTIVIA and is intended to expand ALTIVIA's manufacturing capabilities and global competitiveness in specialty phosgene-derived products used in agricultural, pharmaceutical and industrial applications.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.